Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

590 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Low-dose aspirin for preventing recurrent venous thromboembolism.
Brighton TA, Eikelboom JW, Mann K, Mister R, Gallus A, Ockelford P, Gibbs H, Hague W, Xavier D, Diaz R, Kirby A, Simes J; ASPIRE Investigators. Brighton TA, et al. Among authors: eikelboom jw. N Engl J Med. 2012 Nov 22;367(21):1979-87. doi: 10.1056/NEJMoa1210384. Epub 2012 Nov 4. N Engl J Med. 2012. PMID: 23121403 Free article. Clinical Trial.
Aspirin resistance.
Hankey GJ, Eikelboom JW. Hankey GJ, et al. Among authors: eikelboom jw. Lancet. 2006 Feb 18;367(9510):606-17. doi: 10.1016/S0140-6736(06)68040-9. Lancet. 2006. PMID: 16488805 Review.
Aspirin resistance.
Tran HA, Anand SS, Hankey GJ, Eikelboom JW. Tran HA, et al. Among authors: eikelboom jw. Thromb Res. 2007;120(3):337-46. doi: 10.1016/j.thromres.2006.08.014. Epub 2007 Jan 22. Thromb Res. 2007. PMID: 17241655 Review.
Rationale and design of AVERROES: apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment.
Eikelboom JW, O'Donnell M, Yusuf S, Diaz R, Flaker G, Hart R, Hohnloser S, Joyner C, Lawrence J, Pais P, Pogue J, Synhorst D, Connolly SJ. Eikelboom JW, et al. Am Heart J. 2010 Mar;159(3):348-353.e1. doi: 10.1016/j.ahj.2009.08.026. Am Heart J. 2010. PMID: 20211294 Clinical Trial.
Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial.
Mehta SR, Tanguay JF, Eikelboom JW, Jolly SS, Joyner CD, Granger CB, Faxon DP, Rupprecht HJ, Budaj A, Avezum A, Widimsky P, Steg PG, Bassand JP, Montalescot G, Macaya C, Di Pasquale G, Niemela K, Ajani AE, White HD, Chrolavicius S, Gao P, Fox KA, Yusuf S; CURRENT-OASIS 7 trial investigators. Mehta SR, et al. Among authors: eikelboom jw. Lancet. 2010 Oct 9;376(9748):1233-43. doi: 10.1016/S0140-6736(10)61088-4. Lancet. 2010. PMID: 20817281 Clinical Trial.
Dose comparisons of clopidogrel and aspirin in acute coronary syndromes.
CURRENT-OASIS 7 Investigators; Mehta SR, Bassand JP, Chrolavicius S, Diaz R, Eikelboom JW, Fox KA, Granger CB, Jolly S, Joyner CD, Rupprecht HJ, Widimsky P, Afzal R, Pogue J, Yusuf S. CURRENT-OASIS 7 Investigators, et al. Among authors: eikelboom jw. N Engl J Med. 2010 Sep 2;363(10):930-42. doi: 10.1056/NEJMoa0909475. N Engl J Med. 2010. PMID: 20818903 Free article. Clinical Trial.
Effects of CYP2C19 genotype on outcomes of clopidogrel treatment.
Paré G, Mehta SR, Yusuf S, Anand SS, Connolly SJ, Hirsh J, Simonsen K, Bhatt DL, Fox KA, Eikelboom JW. Paré G, et al. Among authors: eikelboom jw. N Engl J Med. 2010 Oct 28;363(18):1704-14. doi: 10.1056/NEJMoa1008410. Epub 2010 Aug 29. N Engl J Med. 2010. PMID: 20979470 Free article. Clinical Trial.
590 results